Method for predicting the response to a therapy
AssigneeIndex Pharmaceuticals AB
InventorsNikolai Kouznetsov, Lisa Charlotta Bandholtz, Alexander Gielen, Oliver Von Stein, Petra Von Stein
Life of this patent
Estimating the term…
Loading patent…
AssigneeIndex Pharmaceuticals AB
InventorsNikolai Kouznetsov, Lisa Charlotta Bandholtz, Alexander Gielen, Oliver Von Stein, Petra Von Stein
Estimating the term…
The invention concerns an in vitro method for selecting the therapy for a steroid resistant patient, wherein the method comprises isolating cells from a sample taken from said patient; cultivating said isolated cells in the presence of a steroid, an immunomodulatory oligonucleotide or a mixture thereof; determining an expression level of at least one marker gene in said isolated cells; and comparing said expression level of said at least one marker gene to a value obtained from the cultivation of cells from a healthy person in the presence of a steroid, an immunomodulatory oligonucleotide or a mixture thereof, or to a normalized value obtained from a healthy population. Examples of marker genes are CD163, Tsp1, IL1-R2, TLR2, TLR4, MKP-1 and TXK.
An in vitro method for predicting if an immunomodulatory oligonucleotide can re-sensitize a patient suspected of being steroid resistant to the action of steroids, wherein the method comprises the steps of,
Dependencies are inferred from the claim text.